American Orthopaedic Society for Sports Medicine Annual Meeting

American Orthopaedic Society for Sports Medicine Annual Meeting

May 10, 2015
1 min read

No return to OR found 90 days after meniscal allograft transplantation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

CHICAGO — No return to the operating room was found at 90 days following meniscal allograft transplantation, according to a presenter at the International Cartilage Repair Society Annual Meeting.

“The key take-home point to our study is that following meniscal allograft transplantation using our national assessment we had a 90-day return to OR rate of zero,” Frank McCormick, MD, said, here. “However, one in five patients required some kind of concomitant surgery within the 2-year period.”

Frank McCormick


Performing a database search, McCormick and colleagues conducted a retrospective review of 556,521 patients found to have meniscal pathology, with 291 patients undergoing meniscal allograft transplantation between 2007 and 2011. Overall, 21.6% of patients who underwent meniscal allograft transplantation were between the ages of 15 years and 19 years and 18.2% were between the ages of 20 years and 24 years.

At 90 days postoperatively, McCormick noted a 0% incidence of postoperative return to OR rate.

“There is essentially no return to the OR at a 90-day period,” McCormick said. “After 1 year, we saw an increase, but much of that was undergoing chondroplasties and meniscectomies.”

One year and 2 years after surgery, he said the rate of revision meniscal allograft transplantation was 4.5%. The rate of chondroplasty was 4.1% at 1 year and 5.5% at 2 years and the rate of arthroscopic meniscectomy was 5.5% at 1 year and 7.9% at 2 years, according to study results. - by Casey Tingle


Frank RM, et al. Return to OR rates following meniscal allograft transplantation: A retrospective analysis of a US commercial insurance database. Presented at: International Cartilage Repair Society Annual Meeting. May 8-11, 2015; Chicago.

Disclosure: McCormick reports he is a paid presenter or speaker for Genzyme and receives research support from Zimmer.